,0
0,Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program
1,Gilead Sciences: Leading With Passion and Purpose: Sandraâ€™s Story
2,Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
3,Gilead Sciences (GILD) Beats Stock Market Upswing: What Investors Need to Know
4,Jim Simons Stock Portfolio: Top 10 Stock Picks
5,Gilead and Kite Oncology Present Important New Data Across Multiple Difficult-to-Treat Cancers at ESMO Congress 2023
6,Gilead Demonstrates the Impact of Global Collaboration in Advancing HIV Research and Health Equity at EACS 2023
7,2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now
8,"Gilead Sciences to Release Third Quarter 2023 Financial Results on Tuesday, November 7, 2023"
9,Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
